Lentitek Ltd Newsroom

Lentitek strengthens board & funding as commercial traction accelerates

September 24, 2024

Lentitek strengthens board & funding as commercial traction accelerates

EDINBURGH, UK. September 24th, 2024 – Edinburgh based Lentitek Ltd (Lentitek), a developer of a pioneering technology that can enable the delivery of advanced cell and gene therapies, announced ...
Read More
Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies

October 27, 2023

Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies

  Edinburgh, UK – 30 May 2023 – Edinburgh based Lentitek Ltd (Lentitek), a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, an...
Read More
Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies

October 27, 2023

Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies

  Edinburgh, UK – 30 May 2023 – Edinburgh based Lentitek Ltd (Lentitek), a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, an...
Read More
Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies

October 27, 2023

Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies

  Edinburgh, UK – 30 May 2023 – Edinburgh based Lentitek Ltd (Lentitek), a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, an...
Read More